RAP 0.00% 20.5¢ raptor resources limited

Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-136

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 487 Posts.
    lightbulb Created with Sketch. 134
    Yes it is only a screening tool and competes against Snore Lab which it will never surpass but should learn from it - by being free it gets you in and then charges for additional information plus it gives you charts and sleep info that Rap could also expand on - OSA is what Sleep Check recognises but you still need to see a GP for further evaluation and both Apps have this ability of screening for further GP diagnosis - they overlap - had Rap included the diagnostic ability as an add on it would be a completely different product - but management aren’t interested they are chasing the mass market AIMO
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.